Objective: The aim of the study was a comparative investigation by spectral and thermal analysis in order to asses a number of characteristics of different varieties ofrawmaterials of ursodeoxycholic acid and ibuprofen. The different dissolution behavior of two ursodeoxycholic acid pharmaceutical product by crystallinity pattern was investigated. Methods: Raw materials of ursodeoxycholic acid and ibuprofen were used. IR spectroscopy, differential scanning calorimetry and X-Ray Diffraction Analysis were applied. Results: The results show no crystallinitydifferences for different batches of the tested drugs. No solid solid transition was proved during sample preparation for transmission IR analysis. Conclusions: A combination of two more affordabletests by IR spectrometry and differential scanning calorimetry lead to the same results as X-Ray diffraction analysis for crystallinity similarity assessment of the studied substances. The dissolution differences of test drugs were not related to the polymorphism of the raw materials.
1. Patel A, Jones SA, Ferro A, Patel N. Pharmaceutical salts: a formulation trick or a clinical conundrum? Br J Cardiol. 2009;16(6):281-286.
2. Moreno-Calvo E, Calvet T, Cuevas-Diarte MA, Aquilano D. Relationship between the Crystal Structure and Morphology of Carboxylic Acid Polymorphs. Predicted and Experimental Morphologies. Cryst Growth Des. 2010;10(10):4262-4271.
3. Price SL. Predicting crystal structures of organic compounds. ChemSoc Rev. 2014;43:2098-2111.
4. Brittain HG. Polymorphism in Pharmaceutical Solids, Second Edition, Drugs and the Pharmaceutical Sciences, CRC Press. 2009.
5. ***DSC measurement of pharmaceuticals. Hitachi Hi-Tech TA 79. 2007 http://www.hitachi-hightech.com/file/global/pdf/products/science/appli/ana/thermal/application_TA_079e.pdf
6. Zhang GG, Paspal SY, Suryanarayanan R, Grant DJ. Racemic species of sodium ibuprofen: characterization and polymorphic relationships. J Pharm Sci. 2003;92(7):1356-1366.
7. Dudognon E, Correia NT, Danede F, et al. Solid-Solid Transformation in Racemic Ibuprofen. Pharmaceut Res. 2013;30(1):81-89.
8. Kotar A, Kotar M, Sketa P, Plavec J. Potential of Solid-state NMR and SEM in Characterization of Tablets of Ibuprofen. Curr Pharm Anal. 2015;11(2):124-130.
9. Rossi P, Macedi E, Paoli P, et al. Solid Solid Transition between Hydrated Racemic Compound and Anhydrous Conglomerate in Na-Ibuprofen: A Combined X-ray Diffraction, Solid-State NMR, Calorimetric, and Computational Study. Cryst Growth Des. 2014;14(5):2441-2452.
10. Ahuja S, Scypinski S. Handbook of Modern Pharmaceutical Analysis, 2nd Edition, Academic Press. 2010.
11. ***International Pharmacopoeia, 4th Edition, 2013, available on http://apps.who.int/phint/en/p/docf/
12. ***Japanese Pharmacopoeia, 16th Edition, available on http://www.pmda.go.jp/english/pharmacopoeia/
13. Yonemochi E, Ueno Y, Ohmae T, et al. Evaluation of amorphous ursodeoxycholic acid by thermal methods.Pharmaceut Res. 1997;14(6):798-803.